TICKVALE
>⌘K
Nasdaq · CIK 0001576280 · SERVICES-MEDICAL LABORATORIES

GUARDANT HEALTH, INC.

GH chart by TradingView
P/E P/B P/SALES 16.8xEV/EBITDA FCF YIELD -1.21%

PRICE HISTORY

LIVE · NASDAQ
GH chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$1.0B
EBITDA
$-0.4B
FREE CASH FLOW
$-0.2B
EPS
$-3.32
GROSS MARGIN
64.46%
ROIC
-40.55%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 35 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

LATEST · Q2 FY26
Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

P / SALES (TTM)

16.8x
-49%
LATEST · Q2 FY26
16.8xQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26
4.1x51.7x

P / BOOK

+315%
LATEST · Q2 FY26
Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26
7.0x46.2x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

EV / REVENUE (TTM)

17.2x
+191%
LATEST · Q2 FY26
17.2xQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26
5.9x17.2x

FCF YIELD (TTM)

-1.21%
-0.3pp
LATEST · Q2 FY26
-1.21%Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26
-17.35%-0.93%

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$0.3B
+2909%
LATEST · Q2 FY26
0.3BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

EBITDA (DERIVED)

$-0.1B
$0.1B
LATEST · Q2 FY26
-0.1BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

NET INCOME

$-0.1B
$0.1B
LATEST · Q2 FY26
-0.1BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

EPS (DILUTED)

$-0.90
$0.57
LATEST · Q2 FY26
-0.90Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

REVENUE GROWTH YOY

44.33%
-75.3pp
LATEST · Q2 FY26
44.33%Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26
16.52%180.51%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

-20.76%
+42.6pp
LATEST · Q2 FY26
-20.76%Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26
-128.89%-7.44%

RETURN ON CAPITAL

-200.10%
-108.7pp
LATEST · Q2 FY26
-200.10%Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26
-249.46%-40.55%

RETURN ON EQUITY (TTM)

-640.3pp
LATEST · Q2 FY26
Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26
-1087.72%-8.69%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN65.39%
OPERATING MARGIN-38.55%
NET MARGIN-35.87%
FCF MARGIN-20.76%
97.690.79-96.12-193.02-289.92GROSSOPERNETFCFQ1 FY17Q4 FY18Q4 FY19Q4 FY20Q4 FY21Q4 FY22Q4 FY23Q4 FY24Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$-0.1B
$0.1B
LATEST · Q2 FY26
-0.1BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

STOCK-BASED COMP

$0.1B
+7044%
LATEST · Q2 FY26
0.1BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.0B
+192%
LATEST · Q2 FY26
0.0BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

SHARES OUTSTANDING

0.13B
+47%
LATEST · Q2 FY26
0.13BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

DIVIDEND / SHARE

LATEST · Q2 FY26
Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$1.1B
+824%
LATEST · Q2 FY26
1.1BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

TOTAL DEBT

$1.5B
+32%
LATEST · Q2 FY26
1.5BQ1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q1 FY17Q3 FY19Q2 FY21Q1 FY23Q4 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 98.11%INSIDERS 3.97%OTHER / RETAIL 0.00%727 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.8.61%11.6M$1.95B+2.1%
Price (T.Rowe) Associates Inc5.23%7.0M$1.18B+24.6%
Vanguard Portfolio Management LLC4.35%5.8M$983.6MNEW
Vanguard Capital Management LLC4.19%5.6M$947.6MNEW
Invesco Ltd.3.69%4.9M$833.4M-7.0%
Goldman Sachs Group Inc3.31%4.4M$747.4M+68.8%
Two Sigma Investments, LP3.15%4.2M$712.6M+94.7%
FMR, LLC3.07%4.1M$693.5M+71.8%
Geode Capital Management, LLC2.61%3.5M$591.2M+9.2%
Capital International Investors2.59%3.5M$586.5M-1.3%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.